Making science workFind out how

Making science work

Find out how

4th European Workshop on Protein Aggregation and Immunogenicity  | CN 6766

28.01. - 29.01.2019 | Salzburg-Wals, Austria


Austria Trend Comfort Hotel Salzburg West
Bundesstraße 4
5073 Salzburg-Wals
Phone:0043 662 8581 0

Abstract submission:

Participants get the chance to submit abstracts for a poster presentation during the conference. The abstract should be prepared using Microsoft Word as two A4 pages typed in Times New Roman, font size 12. Please submit your abstracts by e-mail to Valentina Marinkova,

Deadline for abstract submission: 30 December 2018.

Exhibition and sponsoring:

For exhibition and sponsoring opportunities please get in touch with the APV headquarters, Valentina Marinkova,

Workshop programme for download

Target groups

The course is designed for all scientists involved in the development and manufacture of therapeutic proteins, working in Pharmaceutical and Biopharmaceutical Industry or at suppliers of analytical equipment or at service companies contributing, e.g. to analytical characterization of therapeutic protein drug products.


Therapeutic protein candidates play an important role in the pipelines of pharmaceutical companies and the marketplace despite of specific analytical, formulation and safety challenges.

This conference, held under the auspices of APV (, will focus on issues of protein aggregation and its impact on the immunogenicity of therapeutic proteins. Gathering opinion leaders from academia, industry and regulatory authorities, the conference will cover a broad range of topics from what causes aggregation of therapeutic proteins in formulation and processing, analytical methods of detecting aggregates, the utility of in vitro and animal models in assessing immunogenicity, to the clinical aspects of therapeutic protein immunogenicity. Options to control aggregates and particles in therapeutic protein formulation and processing will also be discussed from a hands-on experience.

The seminar offers the opportunity to students to present their latest results in poster format, and the display of advanced analytical technology to suppliers in an industrial exhibition.


Karoline Bechtold-Peters

Karoline Bechtold-Peters is pharmacist and holds a Doctor’s degree from the University of Munich as well as a degree as “Fachapotheker” for Pharmaceutical Technology.

She began her industrial career in 1994 at Boehringer Ingelheim in Ingelheim developing solid dosage forms with the focus on powders for inhalation (e.g. Spiriva Inhalet).
In 2000 she changed from the small molecule world to biopharmaceuticals building up Formulation Development at Boehringer Ingelheim’s Biberach site.
In 2003 Karoline took over the responsibility for global clinical supplies, aseptic process development and process transfer within Boehringer Ingelheim Biopharmaceuticals.
Beginning of 2011, Karoline joined F. Hoffmann-La Roche AG in Basel, Switzerland, where she was appointed Head of Clinical Manufacturing, Process Science and Business Excellence.
In September 2016 she moved finally to Novartis in Basel, Switzerland, as Senior Strategy & Technology Leader Pharmaceutics, Global Drug Development / TRD (Biologics) and is part of the BioFuture team.

Karoline is active in various associations (American Association of Pharmaceutical Scientists AAPS, Parenteral Drug Association PDA and International Association for Pharmaceutical Technology APV) and contributes frequently to conferences in the EU as well as in the US.

Vasco Filipe

Vasco Filipe is a Biological Engineer and obtained a Ph.D. degree in Pharmaceutical Sciences from the Utrecht University (The Netherlands) in 2011.
His thesis focused on the physicochemical characteristics, stability in biological fluids and immunogenicity of monoclonal antibody aggregates.
After a post-doc in 2012 on a similar topic, he then joined Adocia in 2013 (Lyon, France), where he worked as the Project Leader for monoclonal antibodies.
In 2015 he joined Sanofi in Paris (France), where he works as a Unit Head in the department of Pharmaceutical Development of Biologics.

Registration fee

  25.11.2018 26.11.2018
Industry 1,390.00 € 1,490.00 €
Authority / University 695.00 € 745.00 €
Students 150.00 € 178.00 €
All prices free of VAT



Phone: +49 6131 97690
Fax: +49 6131 976969